986 related articles for article (PubMed ID: 10897123)
21. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
[TBL] [Abstract][Full Text] [Related]
22. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells.
Suárez L; Vidriales MB; Moreno MJ; López A; García-Laraña J; Pérez-López C; Tormo M; Lavilla E; López-Berges MC; de Santiago M; San Miguel JF; Orfao A;
Haematologica; 2005 Jan; 90(1):54-9. PubMed ID: 15642669
[TBL] [Abstract][Full Text] [Related]
23. Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.
Malagola M; Damiani D; Martinelli G; Michelutti A; Cesana B; Vivo AD; Piccaluga PP; Ottaviani E; Candoni A; Geromin A; Tiribelli M; Fanin R; Testoni N; Lauria F; Bocchia M; Gobbi M; Pierri I; Zaccaria A; Zuffa E; Mazza P; Priccolo G; Gugliotta L; Bonini A; Visani G; Skert C; Bergonzi C; Roccaro AM; Filí C; Baccarani M; Russo D
Br J Haematol; 2007 Jan; 136(1):87-95. PubMed ID: 17222198
[TBL] [Abstract][Full Text] [Related]
24. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
25. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
[TBL] [Abstract][Full Text] [Related]
26. Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up.
Kanerva J; Tiirikainen MI; Mäkipernaa A; Riikonen P; Möttönen M; Salmi TT; Krusius T; Saarinen-Pihkala UM
Pediatr Hematol Oncol; 2001; 18(1):27-36. PubMed ID: 11205837
[TBL] [Abstract][Full Text] [Related]
27. Glutathione system, topoisomerase II level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse.
Massaad-Massade L; Ribrag V; Marie JP; Faussat AM; Bayle C; Dreyfus F; Gouyette A
Anticancer Res; 1997; 17(6D):4647-51. PubMed ID: 9494583
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
[TBL] [Abstract][Full Text] [Related]
29. P-glycoprotein (P-170) expression in acute leukemias.
Abd El-Ghaffar HA; Aladle DA; Farahat SE; Abd El-Hady N
Hematology; 2006 Feb; 11(1):35-41. PubMed ID: 16522547
[TBL] [Abstract][Full Text] [Related]
30. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
Turzanski J; Grundy M; Shang S; Russell N; Pallis M
Exp Hematol; 2005 Jan; 33(1):62-72. PubMed ID: 15661399
[TBL] [Abstract][Full Text] [Related]
31. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
32. Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia.
te Boekhorst PA; Löwenberg B; van Kapel J; Nooter K; Sonneveld P
Leukemia; 1995 Jun; 9(6):1025-31. PubMed ID: 7541095
[TBL] [Abstract][Full Text] [Related]
33. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
Marcucci G; Mrózek K; Ruppert AS; Archer KJ; Pettenati MJ; Heerema NA; Carroll AJ; Koduru PR; Kolitz JE; Sterling LJ; Edwards CG; Anastasi J; Larson RA; Bloomfield CD
J Clin Oncol; 2004 Jun; 22(12):2410-8. PubMed ID: 15197203
[TBL] [Abstract][Full Text] [Related]
34. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.
De Angulo G; Yuen C; Palla SL; Anderson PM; Zweidler-McKay PA
Cancer; 2008 Jan; 112(2):407-15. PubMed ID: 18058809
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.
Roberson JR; Onciu M; Pounds S; Rubnitz JE; Pui CH; Razzouk BI
Pediatr Blood Cancer; 2008 Mar; 50(3):542-8. PubMed ID: 17763467
[TBL] [Abstract][Full Text] [Related]
36. Intracellular IL-4, IL-10, and IFN-gamma levels of leukemic cells and bone marrow T cells in acute leukemia.
Park HH; Kim M; Lee BH; Lim J; Kim Y; Lee EJ; Min WS; Kang CS; Kim WI; Shim SI; Han K
Ann Clin Lab Sci; 2006; 36(1):7-15. PubMed ID: 16501231
[TBL] [Abstract][Full Text] [Related]
37. Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: a report from the Childrens Cancer Group.
Sievers EL; Smith FO; Woods WG; Lee JW; Bleyer WA; Willman CL; Bernstein ID
Leukemia; 1995 Dec; 9(12):2042-8. PubMed ID: 8609715
[TBL] [Abstract][Full Text] [Related]
38. No influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells.
Jamroziak K; Balcerczak E; Cebula B; Janus A; Mirowski M; Robak T
Ther Drug Monit; 2006 Oct; 28(5):707-11. PubMed ID: 17038891
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of CD56 antigen expression in acute myeloid leukemia.
Di Bona E; Sartori R; Zambello R; Guercini N; Madeo D; Rodeghiero F
Haematologica; 2002 Mar; 87(3):250-6. PubMed ID: 11869936
[TBL] [Abstract][Full Text] [Related]
40. Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.
Cavalcanti GB; Vasconcelos FC; Pinto de Faria G; Scheiner MA; de Almeida Dobbin J; Klumb CE; Maia RC
Cytometry B Clin Cytom; 2004 Sep; 61(1):1-8. PubMed ID: 15351976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
